OpenEvidence
Medical information and clinical decision-support company providing an AI platform that synthesizes peer-reviewed research, guidelines and licensed medical content for clinicians.
Key stats
- $985M
- $100M
- 10
- —
- 0
- 2
- Oct 9, 2026
- Financial
- —
- 9 open roles
- 50 % of U.S. physicians
Recent releases
Oct 9, 2026OpenEvidence open roles snapshotOpen roles
A third-party jobs tracker listed nine open roles at OpenEvidence.
Sep 28, 2026OpenEvidence used regularly by more than half of U.S. physiciansUser count
OpenEvidence reported regular use by more than half of U.S. physicians.
Sep 28, 2026OpenEvidence confirms additional $250M fundingFunding round
OpenEvidence confirmed an additional $250 million funding round led by Andreessen Horowitz and Byers Capital.
Sep 23, 2026OpenEvidence begins global localized rolloutAnnouncedProduct launch
OpenEvidence announced a localized version of its clinical decision-support platform for healthcare providers across roughly 100 low- and middle-income countries.
Sep 23, 2026OpenEvidence and Anthropic partner on global medical AI accessAnnouncedPartnership
OpenEvidence and Anthropic partnered to offer a localized clinical decision-support experience free to healthcare providers across roughly 100 low- and middle-income countries.
Jan 21, 2026OpenEvidence used daily by over 40% of U.S. physiciansUser count
OpenEvidence reported daily active use by more than 40% of U.S. physicians across over 10,000 hospitals and medical centers.
Jan 21, 2026OpenEvidence surpasses $100M annual revenueRevenue disclosure
OpenEvidence reported surpassing $100 million in annual revenue.
Jan 21, 2026OpenEvidence raises $250M Series DFunding round
OpenEvidence raised $250 million in a Series D co-led by Thrive Capital and DST Global.
Upcoming
Nothing scheduled.
AI valuation history
Models
| Model | Released | Open source | ||||||
|---|---|---|---|---|---|---|---|---|
| No models recorded. | ||||||||
Platforms & products
| Name | Type | Category | Launched | Status |
|---|---|---|---|---|
| OpenEvidence Global | Product | Global Health | Sep 2026 | rolling out |
| OpenEvidence | Platform | Medical Information Platform | Jan 2023 | active |
Sources
- Oct 9, 2026 · OpenEvidence open roles snapshotStartup Jobs
- Sep 28, 2026 · OpenEvidence used regularly by more than half of U.S. physiciansBecker's Hospital Review
- Sep 28, 2026 · OpenEvidence confirms additional $250M fundingBecker's Hospital Review
- Sep 23, 2026 · OpenEvidence begins global localized rolloutReuters via Mint
- Sep 23, 2026 · OpenEvidence and Anthropic partner on global medical AI accessReuters via Mint
- Jan 21, 2026 · OpenEvidence used daily by over 40% of U.S. physiciansFierce Healthcare
- Jan 21, 2026 · OpenEvidence surpasses $100M annual revenueTechCrunch
- Jan 21, 2026 · OpenEvidence raises $250M Series DTechCrunch
- Dec 31, 2025 · OpenEvidence reaches 18M monthly clinical consultationsTechCrunch
- Oct 20, 2025 · OpenEvidence raises $200M Series CAxios
- Jul 15, 2025 · OpenEvidence raises $210M Series BOpenEvidence
- Feb 20, 2025 · OpenEvidence raises $75M Series AAxios
- Jan 1, 2023 · OpenEvidence launches medical information platformOpenEvidence
* Market cap / valuation. Company values are AI-attributed: the latest market cap or valuation × the share attributed to AI (100% for pure AI companies). Methodology